ES2052639T3 - Analogos de fenilen-, furil- y tienil-leucotrieno b4. - Google Patents

Analogos de fenilen-, furil- y tienil-leucotrieno b4.

Info

Publication number
ES2052639T3
ES2052639T3 ES88109997T ES88109997T ES2052639T3 ES 2052639 T3 ES2052639 T3 ES 2052639T3 ES 88109997 T ES88109997 T ES 88109997T ES 88109997 T ES88109997 T ES 88109997T ES 2052639 T3 ES2052639 T3 ES 2052639T3
Authority
ES
Spain
Prior art keywords
leucotrene
fenilen
tienil
furil
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88109997T
Other languages
English (en)
Spanish (es)
Inventor
Stevan Wakefield Djuric
Richard Arthur Haack
Julie Marion Miyashiro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/067,526 external-priority patent/US4791133A/en
Priority claimed from US07/202,279 external-priority patent/US4895869A/en
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of ES2052639T3 publication Critical patent/ES2052639T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
ES88109997T 1987-06-26 1988-06-23 Analogos de fenilen-, furil- y tienil-leucotrieno b4. Expired - Lifetime ES2052639T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/067,526 US4791133A (en) 1987-06-26 1987-06-26 Phenylene, furyl, and thienyl leukotriene B4 analogues
US07/202,279 US4895869A (en) 1988-06-03 1988-06-03 Phenylene, furyl, and thienyl leukotriene B4 analogues

Publications (1)

Publication Number Publication Date
ES2052639T3 true ES2052639T3 (es) 1994-07-16

Family

ID=26747965

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88109997T Expired - Lifetime ES2052639T3 (es) 1987-06-26 1988-06-23 Analogos de fenilen-, furil- y tienil-leucotrieno b4.

Country Status (6)

Country Link
EP (1) EP0296580B1 (en, 2012)
JP (1) JPS6456645A (en, 2012)
CA (1) CA1325809C (en, 2012)
DE (1) DE3875812T2 (en, 2012)
ES (1) ES2052639T3 (en, 2012)
GR (1) GR3007028T3 (en, 2012)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005045A1 (en) * 1986-12-29 1988-07-14 The Upjohn Company Leukotriene b4 analogs
DE3817385A1 (de) * 1988-05-19 1989-11-30 Schering Ag Neue leukotrien-b(pfeil abwaerts)4(pfeil abwaerts)-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3909327A1 (de) * 1989-03-17 1990-09-20 Schering Ag Neue leukotrien-b4-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3909326A1 (de) * 1989-03-17 1990-09-20 Schering Ag Neue leukotrien-b4-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US5112864A (en) * 1991-05-30 1992-05-12 G. D. Searle & Co. PLA2 inhibitors as antiinflammatories
ITMI20020508A1 (it) * 2002-03-11 2003-09-11 Ghisalberti Carlo Composizioni ad uso topico contenenti derivati furanici

Also Published As

Publication number Publication date
EP0296580B1 (en) 1992-11-11
EP0296580A3 (en) 1989-04-26
CA1325809C (en) 1994-01-04
JPS6456645A (en) 1989-03-03
DE3875812T2 (de) 1993-04-01
EP0296580A2 (en) 1988-12-28
DE3875812D1 (de) 1992-12-17
GR3007028T3 (en, 2012) 1993-07-30

Similar Documents

Publication Publication Date Title
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2150567T3 (es) Antagonistas del factor de liberacion de la corticotropina.
ES2138977T3 (es) Agonistas muscarinicos.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
ES2054872T3 (es) Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
ES2152444T3 (es) Derivados de acido benzazepin-, benzoxazepin- y benzotiazepin-n-acetico, asi como procedimiento para su preparacion y medicamentos que contienen a estos compuestos.
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
ES2056105T3 (es) Di-t-butilfenoles sustituidos.
ES2155052T3 (es) Suela correctora para zapatos, que utiliza un contorno mayor que el plano de estabilidad tecnico ideal.
ES2059377T3 (es) Pirazoles 1,5-diaril-3-sustituidos farmacologicamente activos y procedimiento para sintetizar los mismos.
MX7012A (es) Procedimiento para preparar derivados de acido-cis,endo-2-azabiciclo-(5.3.0.)-decan-3-carboxilico.
ES2040838T3 (es) Compuestos piperazinil-heterociclicos.
ES2188666T3 (es) Analogos de la distamicina utilies como agentes antitumorales o antivirales.
ES2060635T3 (es) Fenilglicinas para usar en la reduccion de la lesion neurotoxica.
ES2154674T3 (es) Derivados de 1,5-benzodiacepinas con actividad antagonista o agonista de cck.
ES2007318A4 (es) Compuestos de imidazol y composiciones biocidas que los comprenden.
ES2045041T3 (es) Triazolinonas sustituidas.
AR029941A1 (es) Compuestos utiles para elevar el nivel plasmatico de la hormona del crecimiento y las composiciones farmaceuticas que las contienen
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
ES8403107A1 (es) Un procedimiento para la preparacion de derivados 2-(2-bencil-3-mercaptopropionilamino)-1-alcanoles quirales.
ES2054740T3 (es) Pentadienamidas paf-antagonistas.
ES2052639T3 (es) Analogos de fenilen-, furil- y tienil-leucotrieno b4.
ES2151716T3 (es) Derivados peptidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 296580

Country of ref document: ES